SARTORIUS STEDIM BIOTECH (56S1.DE) Stock Income Statement
FRA:56S1 • FR0013154002
Current stock price
156.1 EUR
+4.6 (+3.04%)
Last:
| TTM (2026-3-31) | 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.98B | 2.97B | 2.78B | 2.78B | 3.49B | |||
| Minority Interest Expense | -300.00K | -300.00K | -3.40M | -2.40M | -3.80M | |||
| Cost Of Goods | 1.65B | 1.62B | 1.57B | 1.54B | 1.66B | |||
| Gross Profit | 1.33B | 1.35B | 1.21B | 1.23B | 1.83B | |||
| Operating Expenses | 800.70M | 805.80M | 809.00M | 763.20M | 751.80M | |||
| Research and Development | 132.30M | 133.10M | 144.10M | 129.50M | 132.40M | |||
| Selling, General, and Administrative Expenses | 658.20M | 664.80M | 650.50M | 619.50M | 602.60M | |||
| Operating Income | 533.70M | 539.50M | 397.70M | 470.30M | 1.08B | |||
| Interest Income/Expense | -156.60M | -137.10M | -126.10M | -113.40M | -53.00M | |||
| Other Income/Expense | N/A | -14.00M | -9.40M | 59.00M | 147.00M | |||
| Non Recurring Items | N/A | -15.20M | -43.00M | -14.80M | -46.30M | |||
| Income Before Taxes | 377.00M | 373.20M | 219.20M | 401.10M | 1.13B | |||
| Income Tax | 108.20M | 107.30M | 40.70M | 89.00M | 250.50M | |||
| Net Income | 268.30M | 265.60M | 175.10M | 309.70M | 876.10M | |||
| EBITDA | 855.50M | 857.60M | 699.40M | 707.90M | 1.26B | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 2.75 | 2.73 | 1.81 | 3.36 | 9.51 | |||
| Non GAAP EPS | N/A | 4.40 | 3.50 | 4.19 | 8.64 | |||
| Statistics | ||||||||
| Gross Profit Margin | 44.71% | 45.33% | 43.41% | 44.44% | 52.52% | |||
| Profit Margin | 8.99% | 8.95% | 6.30% | 11.16% | 25.08% | |||
| Operating Profit Margin | 17.88% | 18.18% | 14.31% | 16.94% | 31.00% | |||
All data in EUR